These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1386264
1. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin. Akamatsu H, Kurokawa I, Nishijima S, Asada Y. Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264 [Abstract] [Full Text] [Related]
3. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism. Akamatsu H, Niwa Y, Kurokawa I, Masuda R, Nishijima S, Asada Y. Arch Dermatol Res; 1991; 283(8):524-8. PubMed ID: 1838472 [Abstract] [Full Text] [Related]
4. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078 [Abstract] [Full Text] [Related]
6. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB. J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337 [Abstract] [Full Text] [Related]
9. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris. Kurokawa I, Nishijima S, Kawabata S. Eur J Dermatol; 1999 Jul; 9(1):25-8. PubMed ID: 9920982 [Abstract] [Full Text] [Related]
10. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Fluhr JW, Gloor M, Dietz P, Höffler U. Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167 [Abstract] [Full Text] [Related]
11. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. Nishijima S, Kurokawa I, Katoh N, Watanabe K. J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198 [Abstract] [Full Text] [Related]
12. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S. Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569 [Abstract] [Full Text] [Related]
14. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H. Eur J Dermatol; 2005 Feb; 15(3):152-5. PubMed ID: 15908296 [Abstract] [Full Text] [Related]
17. Bacterial resistance in French acne patients. Dumont-Wallon G, Moyse D, Blouin E, Dréno B. Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665 [Abstract] [Full Text] [Related]
18. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis). Puhvel SM, Sakamoto M. J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322 [Abstract] [Full Text] [Related]
19. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. Nishijima S, Kurokawa I, Kawabata S. J Int Med Res; 1996 Jan; 24(6):473-7. PubMed ID: 8959531 [Abstract] [Full Text] [Related]
20. Acne and Propionibacterium acnes. Bojar RA, Holland KT. Clin Dermatol; 2004 Jan; 22(5):375-9. PubMed ID: 15556721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]